Liver function may change how cancer drug works – new study recruits
NCT ID NCT07422610
First seen Mar 03, 2026 · Last updated May 16, 2026 · Updated 16 times
Summary
This study looks at how the drug pelabresib is processed in the body of people with advanced cancer who also have liver problems. It involves about 24 adults whose cancer has not responded to standard treatments. The goal is to understand if liver function affects drug levels, which can help doctors choose the right dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANCIES AND HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Novartis Investigative Site
RECRUITINGLondon, W12 0HS, United Kingdom
Conditions
Explore the condition pages connected to this study.